Selective inhibition of NF‐κB in dendritic cells by the NEMO‐binding domain peptide blocks maturation and prevents T cell proliferation and polarization

Dendritic cells (DC) are the only antigen‐presenting cells for naive T cells and, therefore, they are crucial players in the initiation of immune responses. Because DC maturation and cytokine production are NF‐κB dependent, we hypothesized that blocking NF‐κB activity in DC by selectively targeting the inhibitor of κB (IκB) kinase (IKK) complex using the novel NF‐κB inhibitor NEMO‐binding domain (NBD) peptide could inhibit DC maturation and other functional characteristics, resulting in modulation of the immune response. We used human monocyte‐derived DC to test the biological effects of the NBD peptide in vitro. NF‐κB inhibition by the NBD peptide resulted in blockade of IKK‐mediated IκBα phosphorylation and subsequent nuclear translocation and DNA binding of NF‐κB p65 in DC. In addition, IL‐6, IL‐12, and TNF‐α production was dose‐dependently blocked and NBD peptide treatment also led to a strong reduction of LPS‐induced maturation. Functional analysis of these DC showed marked inhibition of T cell proliferation in the allogeneic mixed lymphocyte reaction, accompanied by less Th1 and Th2 polarization. The current study reveals for the first time the unique properties of this novel, highly specific NF‐κB inhibitor in DC. Also, these data indicate that the NBD peptide could be used as an elegant tool in DC based immunotherapy for unwanted cellular immune responses.

[1]  A. Zwinderman,et al.  Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[2]  A. Bowie,et al.  Poxvirus Protein N1L Targets the I-κB Kinase Complex, Inhibits Signaling to NF-κB by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-κB and IRF3 Signaling by Toll-like Receptors* , 2004, Journal of Biological Chemistry.

[3]  R. Tisch,et al.  Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. , 2004, Blood.

[4]  A. Steinkasserer,et al.  Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83 , 2004, The Journal of experimental medicine.

[5]  S. Ghosh,et al.  Experimental Allergic Encephalomyelitis in the Adoptive Transfer Model of Essential Modifier-Binding Domain Peptides B k Antineuroinflammatory Effect of NF-Fung, , 2004 .

[6]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[7]  L. Adorini,et al.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. , 2004, Seminars in immunology.

[8]  B. Lambrecht,et al.  Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. , 2004, Blood.

[9]  Michael Karin,et al.  The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.

[10]  R. Tisch,et al.  Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI 3 K / Akt pathway and I κ B kinase activity , 2004 .

[11]  M. Kapsenberg.  Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.

[12]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[13]  T. Ichim,et al.  LF15‐0195 generates tolerogenic dendritic cells by suppression of NF‐κB signaling through inhibition of IKK activity , 2003, Journal of leukocyte biology.

[14]  M. Moser.  Dendritic cells in immunity and tolerance-do they display opposite functions? , 2003, Immunity.

[15]  Achsah D. Keegan,et al.  Interleukin-4 and Interleukin-13 Signaling Connections Maps , 2003, Science.

[16]  H. Groux,et al.  The complex role of interleukin-10 in autoimmunity. , 2003, Journal of autoimmunity.

[17]  Fan Yang,et al.  IKKβ Plays an Essential Role in the Phosphorylation of RelA/p65 on Serine 536 Induced by Lipopolysaccharide1 , 2003, The Journal of Immunology.

[18]  I. Bellinghausen,et al.  Production of interleukin‐13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription‐6 , 2003, Immunology.

[19]  M. Feldmann,et al.  Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. , 2003, Blood.

[20]  B. Schnyder,et al.  Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1. , 2002, Biochemical and biophysical research communications.

[21]  Ye Zheng,et al.  Dendritic Cell Development and Survival Require Distinct NF-κB Subunits , 2002 .

[22]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[23]  Ye Zheng,et al.  Dendritic cell development and survival require distinct NF-kappaB subunits. , 2002, Immunity.

[24]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[25]  P. Tak,et al.  NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.

[26]  D. Boldt,et al.  Expression of different NF‐κB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling , 2001, Journal of cellular biochemistry.

[27]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[28]  J. Farrar,et al.  Type I interferons and T helper development. , 2000, Immunology today.

[29]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[30]  Asim Khwaja,et al.  The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte–derived dendritic cells , 2000 .

[31]  P. Kalinski,et al.  Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1 , 2000, The Journal of Immunology.

[32]  J. D. de Fijter,et al.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. , 2000, European journal of immunology.

[33]  S. Akira,et al.  Signal Transducer and Activator of Transcription 6 Is Essential in the Induction of Contact Hypersensitivity , 2000, The Journal of experimental medicine.

[34]  Michael Karin,et al.  The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .

[35]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[36]  M. Karin,et al.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. , 2000, Seminars in immunology.

[37]  K M Ardeshna,et al.  The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. , 2000, Blood.

[38]  M. Biffi,et al.  References Subscriptions Permissions Email Alerts The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I , 2013 .

[39]  P. Ricciardi-Castagnoli,et al.  Brief Definitive Report Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways , 2022 .

[40]  P. Kalinski,et al.  Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. , 1998, Journal of immunology.

[41]  P. Kalinski,et al.  Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. , 1998, Journal of immunology.

[42]  J. Stavnezer,et al.  Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.

[43]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[44]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[45]  V. Verhasselt,et al.  Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor , 1997, European journal of immunology.

[46]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[47]  N. Mackman,et al.  A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. , 1994, The Journal of biological chemistry.

[48]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.